Mpm Bioventures 2018, L.P. - Insider Trading & Ownership

Location
450 Kendall Street, Cambridge, MA
Summary
The estimated value of insider holdings of Mpm Bioventures 2018, L.P. is at least $106M dollars as of May 15, 2025. Mpm Bioventures 2018, L.P. is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $88.6M. Mpm Bioventures 2018, L.P. is the Former 10% Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $17M.
Signature
/s/ Ansbert Gadicke, Managing Director of MPM BioVentures 2018 LLC, the Managing Member of MPM BioVentures 2018 GP LLC, the General Partner of MPM BioVentures 2018, L.P.
All Insider Reports
All Insider Reports

Ownership of Mpm Bioventures 2018, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRDA Entrada Therapeutics, Inc. 10%+ Owner $88.6M -$917K -1.02% Dec 10, 2024
ITOS iTeos Therapeutics, Inc. Former 10% Owner $17M -$5.08M -23% May 13, 2025

Insider Transactions Reported by Mpm Bioventures 2018, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.